News

Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
TikToker Symone Jade noticed a number of surprising side effects after she temporarily stopped taking Mounjaro.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
LLY's oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.
Mounjaro users on Reddit are complaining of developing 'creepy' and 'saggy' skin on their necks after losing weight on GLP-1 ...
Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...